Marc N. Casper - May 8, 2023 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Chairman & CEO, Director
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Stock symbol
TMO
Transactions as of
May 8, 2023
Transactions value $
-$4,470,624
Form type
4
Date filed
5/10/2023, 04:13 PM
Previous filing
May 8, 2023
Next filing
Aug 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $1.58M +10K +7.08% $157.68 151K May 8, 2023 Direct F1
transaction TMO Common Stock Sale -$379K -700 -0.46% $541.85 151K May 8, 2023 Direct F1, F2
transaction TMO Common Stock Sale -$973K -1.79K -1.19% $542.91 149K May 8, 2023 Direct F1, F3
transaction TMO Common Stock Sale -$1.74M -3.2K -2.15% $544.02 146K May 8, 2023 Direct F1, F4
transaction TMO Common Stock Sale -$1.54M -2.83K -1.94% $544.81 143K May 8, 2023 Direct F1, F5
transaction TMO Common Stock Sale -$327K -600 -0.42% $545.71 142K May 8, 2023 Direct F1, F6
transaction TMO Common Stock Sale -$208K -379 -0.27% $548.12 142K May 8, 2023 Direct F1, F7
transaction TMO Common Stock Sale -$275K -500 -0.35% $549.04 141K May 8, 2023 Direct F1, F8
transaction TMO Common Stock Options Exercise $252K +1.6K +1.13% $157.68 143K May 9, 2023 Direct F1
transaction TMO Common Stock Sale -$74.3K -140 -0.1% $530.98 143K May 9, 2023 Direct F1, F9
transaction TMO Common Stock Sale -$376K -704 -0.49% $534.59 142K May 9, 2023 Direct F1, F10
transaction TMO Common Stock Sale -$321K -600 -0.42% $535.54 141K May 9, 2023 Direct F1, F11
transaction TMO Common Stock Sale -$83.7K -156 -0.11% $536.52 141K May 9, 2023 Direct F1, F12
holding TMO Common Stock 2K May 8, 2023 By Alison Casper 2020 Irrevocable Trust F13
holding TMO Common Stock 59.2K May 8, 2023 By Floral Park Associates, Inc.
holding TMO Common Stock 5K May 8, 2023 By MNC 2020 Irrevocable Trust F13
holding TMO Common Stock 3.3K May 8, 2023 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10K -13.37% $0.00 64.8K May 8, 2023 Common Stock 10K $157.68 Direct F14
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -1.6K -2.47% $0.00 63.2K May 9, 2023 Common Stock 1.6K $157.68 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.37 to $542.31, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11) and (12) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.40 to $543.36, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.43 to $544.42, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.43 to $545.31, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.44 to $546.07, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.70 to $548.43, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.99 to $549.12, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $530.85 to $531.30, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.08 to $534.96, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.16 to $535.92, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.42 to $536.70, inclusive.
F13 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F14 The option vested in four equal installments on February 28, 2018, 2019, 2020 and 2021.